U.S. Medical Equipment Stock News

Genius Sports stock slipped about 3% to US$7.60 after the Q2 release, even though the headline numbers told a different story. The company crossed a psychological line by guiding full year revenue to roughly US$1.0b and flagged adjusted earnings before interest, tax, depreciation and amortisation of up to US$295m. For a sports data and betting infrastructure provider that had been defined by potential, this update pushed the conversation squarely toward cash generation and scale. The question...

Assured Guaranty stock just absorbed a sharp reality check. Shares dropped about 9% to roughly US$75, even though the company reported Q2 adjusted operating income of US$55 million, or US$1.23 per share, and highlighted record per share equity metrics. The hit came as investors weighed those solid insurance earnings against softer headline earnings per share of US$0.88 and the reminder that recent results included a large one off gain. For a stock long viewed as a capital return and book...

Central Garden & Pet stock has delivered a strong 40.0% return year to date, yet its low overall value score suggests the current share price may already reflect a lot of optimism. Year to date, Central Garden & Pet is up 40.0%, which puts extra focus on whether recent gains leave enough room for further upside. The planned majority acquisition of European pet supplies company TRIXIE can support longer term growth expectations. At the same time, the timing and execution of this expansion may...

Tariff refunds running into the billions for companies like Apple, Amazon and Walmart are reshaping the legal and compliance battleground in Washington. That money may stay with companies, flow to consumers or trigger tough new rules, and each path creates different winners. This article walks through three U.S. Legal and Compliance Services stocks exposed to this tariff drama so you can evaluate which stories appear more promising or more risky for your own watchlist. The three stocks below...

Zoetis came into this earnings print wearing a value label, trading on an 11.6x trailing P/E that sat well below large pharma peers. The stock then dropped almost 6% in a single session, wiping away any hint of calm around the animal health story. The reason sits squarely in profit pressure. Management cut full year guidance, now pointing to an adjusted diluted earnings per share range of US$6.15 to US$6.25 and organic adjusted net income that is expected to decline mid to high single...

Nutex Health stock jumped 6.7% in the first full trading day after earnings, a sharp move for a company many investors still file mentally under small cap and controversial reimbursement story. The headline is not revenue; the story is profit. Q2 net income reached US$65.8m on revenue of US$210.8m, and trailing net profit margin now sits at 21.2% with a P/E of 6.2x. The market is quickly repricing a business that screens as inexpensive and more profitable than its reputation suggests. Like...

Atlanticus Holdings just saw its stock drop about 11% in a single session, yet the latest quarter reads more like an earnings statement from a company on the front foot than one in retreat. The credit focused lender posted Q2 2026 revenue of US$223.6m and basic earnings per share of US$3.13, both tied to net income of US$47.4m. Investors came into this print after a strong three month run in the stock, which makes the sharp pullback a reset on expectations rather than a simple verdict on the...

Annaly Capital Management stock has delivered a 73.6% return over the past three years, while the current intrinsic value estimate from the Excess Returns model and the earnings based multiples both point to the shares trading at a discount to assessed fair value. At the same time, Annaly scores a mixed result on the broader valuation checks, which keeps the debate open on how much of that discount is usable for investors. A 73.6% return over three years suggests Annaly Capital Management...

The market marked down MarketWise by just over 5% to US$20.25, yet the headline from Q2 is not a collapse in demand. The real story is a sharp squeeze in profitability. Revenue for the quarter sat around US$75.8m, while the company swung to a reported net loss. That pressure also shows up in the trailing net profit margin, which sits at 0.7%, well below where it was a year ago. Today’s price move looks like a fast verdict on that margin strain. It also raises a deeper question about how...

V.F (VFC) just packed several developments into two days. The company reported first quarter results, raised its fiscal 2027 revenue outlook, and named Abhishek Dalmia as Chief Financial Officer. See our latest analysis for V.F. The latest earnings report, higher fiscal 2027 revenue outlook, dividend affirmation and CFO appointment have come as V.F’s share price sits at US$14.99. Short term share price momentum is fading, with the 30 day return down 6.43% and the 90 day return down 21.02%,...

Himax Technologies just jumped 6.3% in a single session, a sharp move for a stock that had been down over the past three months. The market is latching onto one headline: earnings power snapping back in a big way. Basic earnings per share for the quarter came in at about US$0.23 on revenue of roughly US$227.4m, a clear step up from recent prints in this display chipmaker’s cycle. With the stock already trading on a rich trailing P/E of about 72x, the key question now is whether this earnings...

Manitowoc Company just shocked a skeptical market. The stock rose 32.4% to US$18.82 after traders digested a quarter that flipped from a Q1 loss to Q2 basic earnings per share of about US$0.39 and pushed net income to US$14.2m. For a crane maker often viewed as a low margin grinder, the main focus is margin repair. Adjusted EBITDA nearly doubled to US$49m with margin above 8%, helped by stronger crane demand and a meaningful tariff refund tailwind. Love the sharp margin repair at Manitowoc...

In the past week, Figma, Inc. reported second-quarter 2026 results with revenue rising to US$370.08 million from US$249.64 million a year earlier, while swinging from a US$28.23 million net profit to a US$112.15 million net loss and issuing higher full-year 2026 revenue guidance of about US$1.46 billion. The quarter marked Figma’s first full period of AI credit monetization, revealing that new AI features are expanding customer usage even as heavier AI infrastructure spending sharply...

Precision BioSciences stock barely flinched after earnings, edging only 0.9% higher to US$7.49. Yet the quarter itself was anything but quiet. The headline is a sharp swing back into loss making territory, with Q2 basic earnings per share at a loss of US$1.26 and revenue dropping to essentially zero. For a biotech that investors often value on future potential, the real story today is the strain this kind of income statement puts on the balance between patience and dilution risk. The price...

Exponent, Inc. recently reported past second-quarter 2026 results showing year-on-year growth in sales to US$148.86 million, revenue to US$171.61 million, and net income to US$29.4 million, alongside confirming a US$0.31 per-share dividend and completing a multi-year share repurchase of 13,868,342 shares. The company also raised its 2026 revenue growth guidance, signaled further quarterly net revenue growth for the second half of the year, and expanded its equity buyback authorization by...

With the U.S. economy shedding 23,000 jobs in July and inflation holding above 3.5%, reliable dividend growth can feel more valuable than ever. Paychecks are under pressure, yet some companies continue to raise payouts at a measured pace. This article walks through three dividend growth stocks that appear better placed to handle this softer labor backdrop so you can judge whether they deserve a closer look now. The stocks covered below are a useful sample of dividend growth ideas, yet the...

In the past quarter, Western Midstream Partners, LP reported second-quarter 2026 revenue of US$1,224.72 million and net income of US$394.88 million, with basic and diluted EPS from continuing operations of US$0.99, alongside modest impairment charges of US$551,000 and sequential increases in throughput across natural gas, crude oil, NGLs, and produced water. The partnership also affirmed a second-quarter 2026 cash distribution of US$0.930 per unit on an annualized US$3.72 basis and filed a...

Atlassian just delivered the kind of quarter that can reset a story. The stock came into this earnings season already strong over the past few months, then exploded another 35% to about US$149 after the release. That move reflects one thing above all else: profitability is finally showing through in a business many investors still bucket as a pure growth play. Revenue for the fourth quarter sat at about US$1.8b while basic earnings per share came in at US$0.55. A double digit GAAP...

Trade Desk stock just took a beating, closing at US$13.80 and erasing roughly 22% in a single session, even though the core ad tech engine is still producing profit. Q2 revenue came in at US$715 million and adjusted earnings before interest, tax, depreciation and amortization margin held at 34%. The real story is not today’s screen shock. It is how that margin profile, the 13.6% trailing net profit margin and a P/E of 15.9x compare with a long runway of digital ad spend and a valuation that...

EOG Resources (EOG) moved into focus after its Q2 2026 report showed revenue of US$8.62b and net income of US$2.72b, alongside production guidance and a reaffirmed regular dividend. See our latest analysis for EOG Resources. The latest earnings, production guidance and affirmed dividend came after a strong run, with EOG Resources posting a year to date share price return of 25.61% and a 1 year total shareholder return of 19.90%. However, shorter term momentum has faded, with the share price...

Insight Enterprises stock barely moved on the day, edging up just 0.1% to about $149 even as the company reported one of its punchiest earnings updates in years. The market reaction looked muted compared to a quarter anchored by adjusted diluted earnings per share of $3.86 and adjusted EBITDA of $190 million, both sharply ahead of recent run rate. For an information technology solutions stock that had already climbed over the past quarter, this flat performance suggests investors are still...

MercadoLibre stock barely flinched after Q2, slipping about 0.5% to around US$1,820 even as headline numbers landed with real weight. Revenue reached roughly US$10.2b and basic earnings per share came in just above US$9. That muted price move sits against a longer backdrop where the stock has risen over the past three months and yet still trades on a rich trailing P/E near 50x. The key story is not the quarter’s beat or miss noise. It is a deliberate margin squeeze as MercadoLibre pours cash...

Abacus Global Management shares just dropped 8.6% in a single session, yet the latest quarter reads more like an execution win than a collapse in fundamentals. The stock comes into this print after a weak month and a flat few months overall, priced on a premium 32.8x trailing P/E that already assumes a lot. In that context, the real headline is profit quality. Adjusted net income of US$27.1m and a roughly 55% adjusted EBITDA margin landed strong, while a large one off loss in the trailing...

Corsair Gaming just saw its stock jump about 35% to roughly US$14.38, a sharp move for a mid cap gaming hardware company. That reaction hinges on one headline: Q2 brought record gross margin of 33.2% and US$30.8m in adjusted earnings before interest, tax, depreciation and amortisation, powered by high margin peripherals and strong operating cash flow of US$74.8m. Short term traders are chasing the print. Longer term investors are likely to focus on whether this margin and cash engine can hold...